Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

711

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

August 31, 2024

Study Completion Date

December 31, 2030

Conditions
Prostate Cancer
Interventions
BIOLOGICAL

Aglatimagene besadenovec + valacyclovir

"Patients will receive three courses of ProstAtak® each consisting of aglatimagene besadenovec injection + oral valacyclovir. AdV-tk injection will be delivered to the prostate via trans-rectal ultrasound guided injection as follows:~1. The first injection will be given at least 15 days and not more than 8 weeks before starting radiation.~2. The second injection will be 0-3 days before initiation of radiation therapy.~3. The third injection will be 15-22 days after the 2nd injection.~The prodrug, valacyclovir, will be administered at a fixed dose for 14 days after each AdV-tk injection.~Standard external beam radiation therapy will be delivered to the prostate. Short-term androgen deprivation therapy (maximum of 6 months) is optional but must be decided before enrollment to allow for stratification."

BIOLOGICAL

Placebo + valacyclovir

"Patients will receive three courses each consisting of placebo injection + oral valacyclovir. Placebo injection will be delivered to the prostate via trans-rectal ultrasound guided injection as follows:~1. The first injection will be given at least 15 days and not more than 8 weeks before starting radiation.~2. The second injection will be 0-3 days before initiation of radiation therapy.~3. The third injection will be 15-22 days after the 2nd injection.~The prodrug, valacyclovir, will be administered at a fixed dose for 14 days after each placebo injection.~Standard external beam radiation therapy will be delivered to the prostate. Short-term androgen deprivation therapy (maximum of 6 months) is optional but must be decided before enrollment to allow for stratification."

Trial Locations (73)

10468

James J. Peters VA Medical Center, The Bronx

11042

Advanced Radiation Centers of New York (Integrated Medical Professionals), North Hills

13210

Associated Medical Professionals of NY, PLLC, Syracuse

19004

MidLantic Urology, Bala-Cynwyd

20016

Sibley Memorial Hospital, Washington D.C.

20889

Walter Reed National Military Medical Center, Bethesda

21201

VA Maryland Health Care System, Baltimore

21204

Chesapeake Urology Research Associates, Baltimore

21231

The Johns Hopkins University School of Medicine, The Sidney Kimmel Comprehensive Cancer Center, Baltimore

22311

Potomac Urology Center, Alexandria

23249

Hunter Holmes McGuire VA Medical Center, Richmond

23462

Urology of Virginia, PLLC, Virginia Beach

24153

Salem VA Medical Center, Salem

27705

Durham VA Health Care System, Durham

29401

Ralph H. Johnson Veterans Affairs Medical Center, Charleston

29572

Carolina Urologic Research Center, LLC, Myrtle Beach

33060

Clinical Research Center of Florida, Pompano Beach

33324

21st Century Oncology, Fort Lauderdale

21st Century Oncology, Plantation

33612

James A. Haley Veteran's Hospital, Tampa

33615

Florida Urology Partners, Tampa

34102

21st Century Oncology, Naples

34202

21st Century Oncology, Lakewood Rch

45220

Cincinnati VA Medical Center, Cincinnati

60451

Silver Cross Hospital, New Lenox

60612

Jesse Brown VA Medical Center, Chicago

60637

The University of Chicago, Chicago

64128

Kansas City VA Medical Center, Kansas City

68114

Adult & Pediatric Urology, P.C., Omaha

70119

Southeast Louisiana Veterans Health Care System, New Orleans

75216

VA North Texas Health Care System, Dallas

75231

Urology Clinics of North Texas, Dallas

77030

Dr. Irving Fishman's Office, Houston

77070

Houston Willowbrook Radiation Oncology, Houston

77074

Dr. Ned Stein's Office, Houston

77375

Texas Urology Specialists, Tomball

77385

Texas Urology Specialists-The Woodlands, The Woodlands

The Methodist Hospital - The Woodlands, The Woodlands

78229

The University of Texas Health Science Center at San Antonio, San Antonio

78705

Urology Austin, Austin

78758

Austin Urology Institute, Austin

78759

Austin Urology Institute - Northwest Austin Cancer Center, Austin

80134

Advanced Urology, Parker

80228

Colorado Clinical Research, Lakewood

81601

Valley View Hospital, Glenwood Springs

85027

Arizona Center for Cancer Care - Deer Valley, Phoenix

85251

Arizona Center for Cancer Care - Osborne, Scottsdale

85258

Arizona Center for Cancer Care - Shea, Scottsdale

85260

Arizona Oncology Services Foundation, Multiple Locations

85297

Arizona Center for Cancer Care - Gilbert, Gilbert

85308

Arizona Urology Specialists, Glendale

85374

Arizona Center for Cancer Care - Surprise, Surprise

85381

Arizona Center for Cancer Care - Peoria, Peoria

85723

Southern Arizona VA Health Care System, Tucson

87109

New Mexico Oncology Hematology Consultants (NMOHC), Albuquerque

87131

University of New Mexico Cancer Center, Albuquerque

89144

Sheldon Freedman MD, Ltd., Las Vegas

89502

VA Sierra Nevada Health Care System, Reno

92780

Precision Radiation Oncology, Tustin

95655

VA Northern California Health Care System, Mather

97239

VA Portland Health Care System, Portland

97477

Oregon Urology Institute, Springfield

98335

MultiCare Regional Cancer Center - Gig Harbor, Gig Harbor

98405

MultiCare Regional Cancer Center - Tacoma, Tacoma

01605

University of Massachusetts Medical School, Worcester

08003

New Jersey Urology - Cherry Hill, Cherry Hill

07631

New Jersey Urology - Englewood, Englewood

07041

New Jersey Urology - Milburn, Millburn

07663

New Jersey Urology - Saddle Brook, Saddle Brook

07052

New Jersey Urology - West Orange, West Orange

19111-2497

Fox Chase Cancer Center, Philadelphia

78229-4404

South Texas San Antonio VA Healthcare System, San Antonio

00921

VA Caribbean Healthcare System, San Juan

Sponsors
All Listed Sponsors
lead

Candel Therapeutics, Inc.

INDUSTRY

NCT01436968 - Phase 3 Study of ProstAtak® Immunotherapy With Standard Radiation Therapy for Localized Prostate Cancer | Biotech Hunter | Biotech Hunter